DR

Dimpalben Ranchhodbhai Jagotiya

Active Director Director DIN 09661160
DIN 09661160 First appointment Jul 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Dimpalben Ranchhodbhai Jagotiya

Data last updated:

Dimpalben Ranchhodbhai Jagotiya is a Director at Gallop Pharma Distributors Private Limited (since 2022). The company operates in Pharma.

DIN 09661160
Primary Designation Director
Industry Pharma
First Appointment 04 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jul 20222022Active

Board colleagues of Dimpalben Ranchhodbhai Jagotiya

Directorship timeline

Open interactive timeline →
Gallop Pharma Distributors Private Limited
Premium access

Shareholding and investment profile for Dimpalben Ranchhodbhai Jagotiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dimpalben Ranchhodbhai Jagotiya

Dimpalben Ranchhodbhai Jagotiya currently holds 1 directorship: Gallop Pharma Distributors Private Limited (Director, since 04 Jul 2022).

Dimpalben Ranchhodbhai Jagotiya was first appointed on 04 Jul 2022 as Director at Gallop Pharma Distributors Private Limited.

The current boards of Dimpalben Ranchhodbhai Jagotiya's companies include Ranchod Motilal Jagotiya (Gallop Pharma Distributors Private Limited), Shankarlal Bhavarlal Shah (Gallop Pharma Distributors Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available